Becton Dickinson (BDX)
NYSEHealth CareMedical Instruments & SuppliesSnapshot 2026-07-08
$150.51-3.70%
Close 2026-07-08 · 1-day change
Reading BDX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BDX free→NYSEHealth CareMedical Instruments & SuppliesSnapshot 2026-07-08
Reading BDX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BDX free→QuarterlyIQ Insights · BDX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 22,158.0 | 21,840.0 | 20,178.0 | 19,372.0 | 18,870.0 | 19,131.0 | 16,074.0 | 17,290.0 | 12,483.0 | 12,483.0 | 12,483.0 | 10,282.0 | 7,708.0 | 7,708.0 | 7,708.4 | 7,828.9 | 6,897.6 | 7,074.9 |
| Total Revenues | 22,158.0 | 21,840.0 | 20,178.0 | 19,372.0 | 18,870.0 | 19,131.0 | 16,074.0 | 17,290.0 | 12,483.0 | 12,483.0 | 12,483.0 | 10,282.0 | 7,708.0 | 7,708.0 | 7,708.4 | 7,828.9 | 6,897.6 | 7,074.9 |
| Cost of Revenues | 11,764.0 | 11,915.0 | 11,053.0 | 11,202.0 | 10,393.0 | 10,500.0 | 9,276.0 | 9,002.0 | 6,492.0 | 6,492.0 | 6,492.0 | 5,587.0 | 3,755.0 | 3,755.0 | 3,755.4 | 3,737.4 | 3,357.2 | 3,446.8 |
| Gross Profit | — | — | — | — | — | — | 7,577.0 | 8,288.0 | 7,262.0 | 5,991.0 | 5,991.0 | 4,695.0 | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 5,449.0 | 5,278.0 | 4,857.0 | 4,719.0 | 4,709.0 | 4,719.0 | 4,185.0 | 4,332.0 | 3,005.0 | 3,005.0 | 3,005.0 | 2,563.0 | 1,923.0 | 1,923.0 | 1,923.4 | 1,851.8 | 1,669.8 | 1,695.6 |
| R&D Expenses | 1,245.0 | 1,265.0 | 1,190.0 | 1,237.0 | 1,256.0 | 1,279.0 | 1,039.0 | 1,062.0 | 828.0 | 828.0 | 828.0 | 632.0 | 472.0 | 472.0 | 471.8 | 476.5 | — | — |
| Other Operating Expenses, Total | (449.0) | (396.0) | (222.0) | 210.0 | (37.0) | (203.0) | (363.0) | (654.0) | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
| Operating Income | 2,388.0 | 2,579.0 | 2,397.0 | 2,111.0 | 2,282.0 | 2,250.0 | 912.0 | 1,760.0 | 1,430.0 | 1,430.0 | 1,430.0 | 1,074.0 | 1,558.0 | 1,558.0 | 1,557.9 | 1,763.3 | 1,488.1 | 1,536.9 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 613.0 | 528.0 | 452.0 | 398.0 | 469.0 | 528.0 | 639.0 | 388.0 | 388.0 | 388.0 | 371.0 | 135.0 | 135.0 | 134.7 | 84.0 | 36.3 | 36.3 |
| Interest & Investment Income | 23.0 | 38.0 | 163.0 | 49.0 | 16.0 | 9.0 | 7.0 | 12.0 | 21.0 | 21.0 | 21.0 | 15.0 | 50.0 | 50.0 | — | — | — | — |
| Net Interest Expenses | — | 575.0 | 365.0 | 403.0 | 382.0 | 460.0 | 521.0 | 627.0 | 367.0 | 367.0 | 367.0 | 356.0 | 85.0 | 85.0 | — | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | — | 214.0 | 72.0 | 72.0 | 72.0 | — | 9.0 | 9.3 | 9.3 | — | — |
| EBT, Incl. Unusual Items | 1,806.0 | 1,881.0 | 2,005.0 | 1,662.0 | 1,783.0 | 1,692.0 | 985.0 | 1,176.0 | 1,074.0 | 1,074.0 | 1,074.0 | 739.0 | 1,472.0 | 1,472.0 | 1,472.4 | 1,716.3 | 1,489.7 | 1,538.4 |
| Income Tax Expense | 244.0 | 203.0 | 300.0 | 132.0 | 148.0 | 88.0 | 62.0 | (57.0) | 97.0 | 97.0 | 97.0 | 44.0 | 363.0 | 363.0 | 362.9 | 451.4 | 411.9 | 422.5 |
| Net Income | ||||||||||||||||||
| Net Income | 1,138.0 | 1,678.0 | 1,705.0 | 1,484.0 | 1,779.0 | 2,092.0 | 874.0 | 1,233.0 | 976.0 | 976.0 | 976.0 | 695.0 | 1,170.0 | — | — | — | — | 1,127.0 |
| Per Share | ||||||||||||||||||
| Basic EPS | 4.06 | 5.83 | 5.88 | 4.97 | 5.93 | 6.92 | 2.75 | 4.01 | 4.59 | 4.59 | 4.59 | 3.43 | 5.69 | 5.69 | 5.69 | 5.75 | 4.61 | 4.61 |
| Diluted EPS | 4.06 | 5.82 | 5.86 | 4.94 | 5.88 | 6.85 | 2.71 | 3.94 | 4.49 | 4.49 | 4.49 | 3.35 | 5.59 | 5.59 | 5.59 | 5.62 | 4.46 | 4.46 |
| Revenue per Share | 78.96 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 280.6 | 287.6 | 289.8 | 286.3 | 285.0 | 289.3 | 279.0 | 269.9 | 212.7 | 212.7 | 212.7 | 202.5 | 205.5 | 205.5 | 205.5 | 221.2 | 244.3 | — |
| Diluted Weighted Avg Shares | 280.6 | 288.5 | 291.0 | 288.4 | 287.4 | 292.1 | 282.4 | 274.8 | 217.5 | 217.5 | 217.5 | 207.5 | 209.2 | 209.2 | 209.2 | 226.3 | 252.7 | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 5,041.0 | 4,683.0 | 4,399.0 | 4,511.0 | 4,480.0 | 3,027.0 | 4,013.0 | 2,544.0 | 2,544.0 | 2,544.0 | 1,965.0 | 2,069.0 | 2,069.0 | 2,068.8 | 2,267.4 | 1,960.1 | 2,014.0 |
| EBIT | 2,388.0 | 2,579.0 | 2,397.0 | 2,111.0 | 2,282.0 | 2,250.0 | 912.0 | 1,760.0 | 1,430.0 | 1,430.0 | 1,430.0 | 1,074.0 | 1,558.0 | 1,558.0 | 1,557.9 | 1,763.3 | 1,488.1 | 1,536.9 |
| Effective Tax Rate | 13.5% | 10.8% | 15.0% | 7.9% | 8.3% | 5.2% | 6.3% | -4.8% | 9.0% | 9.0% | 9.0% | 6.0% | 24.7% | 24.7% | 24.6% | 26.3% | 27.7% | 27.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.